Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints.
Schmidt M, Arjomand-Wölkart K, Birkhäuser MH, Genazzani AR, Gruber DM, Huber J, Kölbl H, Kreft S, Leodolter S, Linsberger D, Metka M, Simoncini T, Vrabic Dezman L.
Schmidt M, et al.
Gynecol Endocrinol. 2016 Jun;32(6):427-30. doi: 10.3109/09513590.2016.1152240. Epub 2016 Mar 4.
Gynecol Endocrinol. 2016.
PMID: 26943176
Free article.